Actionable insights straight to your inbox

logo_equities.svg

Ruthigen, Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-K Item 405] (Jun. 30, 2014)

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission
  • 1 min Read

By Equities News Author

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Ruthigen, Inc. (Form 10-K) was posted on June 30, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There were 11 documents filed with this form. The SEC file number is 0001144204-14-040451.
The contact information for this company is 2455 BENNETT VALLEY RD. SUITE C116, SANTA ROSA CA 95404, (707) 525-9900.
Our editors provided additional information about Form 10-K: This is the annual report that most reporting companies file with the Commission. It provides a comprehensive overview of the registrant’s business. The report must be filed within 90 days after the end of the company’s fiscal year.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1574235/0001144204-14-040451-index.html.
Keywords for this news article include: Pharmaceutical Preparations, SEC Filing, Ruthigen Inc..
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

  • More in Investing & Finance

Semiconductor Stocks Rebound, But Sector Still Has Issues

With pandemic-induced supply chain bottlenecks receding, semiconductor stocks have been riding a bullish trend, making higher lows and higher highs.

It’s Easy For Leaders to Play the Blame Game. Don’t.

To say the current situation isn’t pretty now seems an understatement, and it’s likely to remain chaotic for a while. Which is why it’s so important for leaders of all kinds not to fall prey to the very human tendency to go negative.

This Prestigious Bank Is Down 90% — Is Now the Time to Buy?

Bargain-hunting friends of mine have been asking: “Should I buy First Republic?” After all, First Republic is prestigious. Facebook founder Mark Zuckerberg got a mortgage there. Dozens of customer surveys rate its satisfaction scores higher than super-brands like Apple and Ritz-Carlton.

Recession Odds Rising (Plus: Jay Powell, Meet Sal Dali)

Many of us economy-watchers have been expecting recession, though with significant differences on odds and timing. Regardless, recent banking developments just made recession more likely and may have accelerated its onset.

Semiconductor Stocks Rebound, But Sector Still Has Issues

  • 3 min Read 
logo_equities_white

Sign up For our Newsletter

SITEMAP

Contact

© 2022 Equities News | Equities.com, Inc.